Topical imiquimod and in situ vulvar melanoma: A promising therapy?
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70087 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Francesca Pepe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermato-Oncology Unit, European Institute of Oncology IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Aminoquinolines, Antineoplastic Agents, Melanoma, Vulvar Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Vulvar melanoma is a rare type of cancer that affects mainly postmenopausal women. There are no established protocols for the treatment of vulvar melanoma. From data extrapolated from the literature on cutaneous melanoma, surgical excision remains the best option for the resectable disease. Imiquimod, a topical immunomodulator, has been used in selected cases of in situ vulvar melanoma. Methods and Results We reported two cases of in situ vulvar melanoma treated with topical imiquimod 5%, either as first‐line therapy or adjuvant treatment, that showed a complete clinical response to topical treatment.
Conclusion
Imiquimod's beneficial and adverse effects in in situ vulvar melanoma treatment are examined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermato-Oncology Unit, European Institute of Oncology IRCCS, Milan, Italy.
- Preventive Gynecology Unit, European Institute of Oncology IRCCS, Milan, Italy.
- Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
- Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology IRCCS, Milan, Italy.
ORCID-Profile: Francesca Pepe
Zitieren
APA
Pepe, F., Silvestri, F., Preti, E. P., Iacobone, A. D., Radici, G., Vaccari, S., Queirolo, P., & Tosti, G. (2025). Topical imiquimod and in situ vulvar melanoma: A promising therapy?. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70087
Vancouver
Pepe F, Silvestri F, Preti EP, Iacobone AD, Radici G, Vaccari S, et al. Topical imiquimod and in situ vulvar melanoma: A promising therapy?. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70087
BibTeX
@article{Pepe2025,
author = {Pepe, Francesca and Silvestri, Flavia and Preti, Eleonora Petra and Iacobone, Anna Daniela and Radici, Gianluigi and Vaccari, Sabina and Queirolo, Paola and Tosti, Giulio},
title = {Topical imiquimod and in situ vulvar melanoma: A promising therapy?},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70087}
}
EUVIMED